A practical roadmap for navigating DEA transfers, PBM credentialing, staff retention, and patient file continuity from day one through month twelve.
Find Pharmacy Businesses to AcquireClosing a pharmacy acquisition is only the beginning. The weeks and months that follow determine whether the patient base stays, staff remain licensed and engaged, and PBM reimbursements flow without interruption. Independent pharmacies carry unique regulatory obligations — DEA registrations, state board approvals, and payer credentialing — that require immediate action at close. This guide walks acquirers through a phased integration plan built specifically for retail, compounding, and specialty pharmacy transactions in the $1M–$5M revenue range.
Goals
Key Actions
Goals
Key Actions
Goals
Key Actions
Reimbursement Interruption from Delayed PBM Credentialing
Failing to notify PBM networks at close causes claim rejections and cash flow gaps. Submit credentialing packets on day one and track each network's credentialing timeline proactively.
Losing the Licensed Pharmacist-in-Charge
If the departing owner was the pharmacist-in-charge, operations can halt without a licensed replacement. Identify and designate a new PIC before close, not after.
Underestimating Patient Attrition During Transition
Patients loyal to the prior owner may transfer prescriptions elsewhere if communication is poor. A proactive patient communication plan in the first 30 days is essential to file retention.
Ignoring DIR Fee Exposure in Acquired PBM Contracts
Retrospective DIR fees from inherited PBM contracts can arrive months after close and materially reduce EBITDA. Review all contracts for DIR clawback provisions before assuming them.
Typically 30–90 days for full registration. Acquirers should request interim dispensing authorization from the DEA immediately at close to avoid any gap in controlled substance dispensing authority.
No. The DEA requires the new owner to obtain their own registration. Operating under the seller's DEA number post-close is a federal violation with serious legal and licensing consequences.
PBM contracts generally do not transfer automatically in an asset purchase. Each PBM must be notified, new credentialing submitted, and network acceptance confirmed before claims can be processed under the new owner's NPI.
Offer retention agreements with a 12–24 month commitment bonus tied to stay, communicate role stability early, and involve key pharmacists in operational decisions to reduce uncertainty-driven turnover during the transition.
More Pharmacy Guides
DealFlow OS surfaces off-market targets with seller signals and outreach angles. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers